The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 25901531 |
211 |
Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94. |
Sloan-Kettering Institute For Cancer Research |
| 23965125 |
26 |
Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series. |
Memorial Sloan-Kettering Cancer Center |
| 16854066 |
44 |
Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90. |
Infinity Pharmaceuticals |
| 30351001 |
16 |
Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis. |
China Pharmaceutical University |
| 29057043 |
40 |
Resorcinol-Based Grp94-Selective Inhibitors. |
The University of Kansas |
| 29528635 |
14 |
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. |
Hauptman-Woodward Medical Research Institute |
Search and Browse
